280 related articles for article (PubMed ID: 24939870)
41. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.
Li JL; Harris AL
Front Biosci (Landmark Ed); 2009 Jan; 14(8):3094-110. PubMed ID: 19273260
[TBL] [Abstract][Full Text] [Related]
42. Endothelial Jagged1 Antagonizes Dll4/Notch Signaling in Decidual Angiogenesis during Early Mouse Pregnancy.
Marchetto NM; Begum S; Wu T; O'Besso V; Yarborough CC; Valero-Pacheco N; Beaulieu AM; Kitajewski JK; Shawber CJ; Douglas NC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899448
[TBL] [Abstract][Full Text] [Related]
43. Activation of Notch signaling by soluble Dll4 decreases vascular permeability via a cAMP/PKA-dependent pathway.
Boardman R; Pang V; Malhi N; Lynch AP; Leach L; Benest AV; Bates DO; Machado MJC
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1065-H1075. PubMed ID: 30681366
[TBL] [Abstract][Full Text] [Related]
44. Notch signaling regulates tumor angiogenesis by diverse mechanisms.
Dufraine J; Funahashi Y; Kitajewski J
Oncogene; 2008 Sep; 27(38):5132-7. PubMed ID: 18758482
[TBL] [Abstract][Full Text] [Related]
45. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.
Liu ZJ; Shirakawa T; Li Y; Soma A; Oka M; Dotto GP; Fairman RM; Velazquez OC; Herlyn M
Mol Cell Biol; 2003 Jan; 23(1):14-25. PubMed ID: 12482957
[TBL] [Abstract][Full Text] [Related]
46. Dll4-containing exosomes induce capillary sprout retraction in a 3D microenvironment.
Sharghi-Namini S; Tan E; Ong LL; Ge R; Asada HH
Sci Rep; 2014 Feb; 4():4031. PubMed ID: 24504253
[TBL] [Abstract][Full Text] [Related]
47. Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma.
Ye X; Abou-Rayyah Y; Bischoff J; Ritchie A; Sebire NJ; Watts P; Churchill AJ; Bates DO
J Pathol; 2016 Jun; 239(2):139-51. PubMed ID: 26957058
[TBL] [Abstract][Full Text] [Related]
48. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
49. The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC.
Kiec-Wilk B; Grzybowska-Galuszka J; Polus A; Pryjma J; Knapp A; Kristiansen K
J Physiol Pharmacol; 2010 Apr; 61(2):217-25. PubMed ID: 20436223
[TBL] [Abstract][Full Text] [Related]
50. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
Yang MH; Chang KJ; Li B; Chen WS
Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
[TBL] [Abstract][Full Text] [Related]
51. ETS factors regulate Vegf-dependent arterial specification.
Wythe JD; Dang LT; Devine WP; Boudreau E; Artap ST; He D; Schachterle W; Stainier DY; Oettgen P; Black BL; Bruneau BG; Fish JE
Dev Cell; 2013 Jul; 26(1):45-58. PubMed ID: 23830865
[TBL] [Abstract][Full Text] [Related]
52. Analysis of Molecular Mechanism of YiqiChutan Formula Regulating DLL4-Notch Signaling to Inhibit Angiogenesis in Lung Cancer.
Li J; Han R; Li J; Zhai L; Xie X; Zhang J; Chen Y; Luo J; Wang S; Sun Z; Cao Y; Lin L; Yang Q
Biomed Res Int; 2021; 2021():8875503. PubMed ID: 33628824
[TBL] [Abstract][Full Text] [Related]
53. Delta-like ligand 4-notch blockade and tumor radiation response.
Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
[TBL] [Abstract][Full Text] [Related]
54. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.
Yen WC; Fischer MM; Hynes M; Wu J; Kim E; Beviglia L; Yeung VP; Song X; Kapoun AM; Lewicki J; Gurney A; Simeone DM; Hoey T
Clin Cancer Res; 2012 Oct; 18(19):5374-86. PubMed ID: 22952347
[TBL] [Abstract][Full Text] [Related]
55. High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
Negri F; Bozzetti C; Pedrazzi G; Azzoni C; Bottarelli L; Squadrilli A; Lagrasta C; Tamagnini I; Bisagni A; Ragazzi M; Porzio R; Tomasello G; Mori D; Leonardi F; Gnetti L; Crafa P; Sala R; Cascinu S
Oncol Rep; 2019 Dec; 42(6):2750-2758. PubMed ID: 31578584
[TBL] [Abstract][Full Text] [Related]
56. Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.
Chen H; Liu D; Yang Z; Sun L; Deng Q; Yang S; Qian L; Guo L; Yu M; Hu M; Shi M; Guo N
Endocr Relat Cancer; 2014 Oct; 21(5):783-95. PubMed ID: 25179535
[TBL] [Abstract][Full Text] [Related]
57. Substrate stiffness modulates endothelial cell function via the YAP-Dll4-Notch1 pathway.
Matsuo E; Okamoto T; Ito A; Kawamoto E; Asanuma K; Wada K; Shimaoka M; Takao M; Shimamoto A
Exp Cell Res; 2021 Nov; 408(1):112835. PubMed ID: 34543658
[TBL] [Abstract][Full Text] [Related]
58. Endothelial HIF2α suppresses retinal angiogenesis in neonatal mice by upregulating NOTCH signaling.
Duan LJ; Jiang Y; Fong GH
Development; 2024 Jun; 151(11):. PubMed ID: 38770916
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
[TBL] [Abstract][Full Text] [Related]
60. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
